Bevacizumab in recurrent glioma
Author(s) -
SujithKumar Mullapally,
Pankaj Kumar Panda
Publication year - 2021
Publication title -
cancer research statistics and treatment
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2590-3233
pISSN - 2590-3225
DOI - 10.4103/crst.crst_172_21
Subject(s) - bevacizumab , glioma , medicine , antiangiogenic therapy , oncology , vegf receptors , cancer research , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom